UNSPSC 51111853: Inocoterone

This classification denotes an anti-androgen with the molecular formula C18H26O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ONU02D116S, chemically known as (3S,3aS,9aS,9bS)-6-ethyl-3-hydroxy-3a-methyl-2,3,4,5,8,9,9a,9b-octahydro-1H-cyclopenta[a]naphthalen-7-one but generally known as inocoterone, which bears US NIH Compound Identifier 11776794. European Medicines Agency schedules inocoteronein its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08189MIG.

Most nations schedule inocoterone under HS 29379000 and SITC 54155. As of Q4 2014, INOCOTERONE remains the US FDA Preferred Term for this commodity. SMILES: CCC1=C2CCC3(C(C2CCC1=O)CCC3O)C.

UNSPSC 51111853 Inocoterone (Commodity) appears in state and local procurement records with no recent opportunities visible in current sourcing activity. The code describes a pharmaceutical or chemical compound, but the available recent-opportunities block contains no state or local solicitations tagged to this code. Without active procurement records, the current scope of work, issuing-body participation, and geographic distribution cannot be characterized from recent buying patterns.

If state and local governments are procuring inocoterone through this code, the activity is not surfacing in public bid notices or the available opportunity dataset as of this summary date. Business development professionals should monitor this code for future activity or consider whether related pharmaceutical or chemical codes (particularly within the broader 51111000 pharmaceutical family) may capture the actual buying behavior they are tracking.